GPhC confirms increase in renewal fees from July despite opposition

The General Pharmaceutical Council (GPhC) has confirmed it is increasing its renewal fee for pharmacists by £7 to £257, despite opposition from 70% of pharmacy professionals.

GPhC_620.jpg
GPhC: New fee for pharmacists will still be below 2011 level

It will also increase premises renewal fees by £21 to £262 and pharmacy technician fees by £3 to £121 from July, it announced on Friday (March 8).

The decision follows a consultation – which ran from November 2018 to January 2019 – in which 70% of the 5,409 pharmacy professionals and organisations responding disagreed with increasing the fees for pharmacists.

Furthermore, 66% of respondents disagreed with increasing the fees for pharmacy technicians and 51% opposed increasing premises fees.

“Some respondents called on the GPhC to demonstrate further efficiency savings, and for more flexible fee options to account for differences in income; for example, for people on parental leave or who work part-time,” the regulator said.

Chief executive Duncan Rudkin said: “Our role is to protect the public and give them assurance that they will receive safe and effective care when using pharmacy services.

“We have to make sure we have the resources necessary to carry out our regulatory functions effectively on their behalf.”

The new fee for pharmacists will still be lower than the 2011 level of £267, and marks the first increase since 2015, it stressed.

In its annual plan for 2019-20, the GPhC outlined ways it intends to “improve efficiency and effectiveness”, including the possibility of moving from its offices in Canary Wharf, London.

The Twitter reaction

Sign in or register for free

Latest from News

‘Very desperate’: Boom in pay-for-DPP services as GP surgery ‘doors close’

 
• By 
 • comment

A snowballing number of pharmacists who “feel like they're missing out” are willing to fork out thousands for a Designated Prescribing Practitioner (DPP) to complete their independent prescribing (IP) qualification, C+D has learned.

Patient secures ‘urgent’ leukaemia treatment after Pharmacy First consultation

 
• By 
 • comment

A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.

PDA releases ‘six-step test’ for the next funding contract

 
• By 
 • comment

It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.

More from Regulation